home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Driving Autoreactive Cells to Distraction

  October, 1 2009 17:27
your information resource in human molecular genetics

How potentially autoreactive T cells are prevented from being 'switched on' is reported in a paper published online in Nature Immunology. Explaining how these potentially harmful cells are activated could lead to new therapies for the prevention of autoimmune diseases, such as diabetes.

Previous work showed that PD-1, a protein expressed on autoreactive T lymphocytes, is essential to prevent autoimmunity and maintain immune cell tolerance for self proteins in mice.

Using a mouse model of type 1 diabetes, Brian Fife and co-workers found that blockade of PD-1 caused a slowdown in the movement of autoreactive T cells. This decreased spontaneous movement allowed autoreactive T cells the opportunity to recognize pancreatic islet cell components. The subsequent release of proinflammatory mediators caused islet cell destruction and clinical diabetes.

Whether these findings are relevant to other T cell-driven autoimmune diseases remains to be seen.

Author contact:

Brian Fife (University of Minnesota, Minneapolis, MN, USA)
E-mail: bfife@umn.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.